Friday, August 2, 2013

Cordlife Group : Keeping the best for our children (AM)

Cordlife Group Limited
LAST CLOSE: S$1.05
FAIR VALUE: S$1.32

We initiate coverage on Cordlife Group Limited (CLGL) with a Buy rating and target price (TP) of $1.32. CLGL is a leading provider of cord blood and umbilical tissue storage services in Singapore, Hong Kong, India, Indonesia and the Philippines. We view the low penetration rates of the stem cells storage industry as an opportunity for investors to ride on the industry’s growth potential in Asia.

Defensive qualities with sustainable recurring cash flow. CLGL provides attractive exposure to the defensive healthcare universe amid broad market decline. The Group presents a strong business model which generates sustainable recurring cash flows from its growing subscription base. Building on economies of scale, the Group in expected to sustain its high margins in the long term.


Accretive acquisitions to drive earnings. CLGL acquisitions of subsidiaries in India, Indonesia, and the Philippines potentially strengthens the Group’s geographical positioning in Asia. Each subsidiary has significant market leadership in cord blood banking which would enhance the Group’s earnings power hence making it a compelling value proposition.

Expanding product offerings for further organic growth. Leveraging on its strong relationship with the local obstetricians and gynaecologists (OBGYN) network and partnerships with local hospitals, CLGL sees many opportunities in catering services for women and children. Besides introducing umbilical tissue storage service in Singapore which generates a new stream of income, the Group looks to pursue vertical expansion with future product introductions in the pipeline.

Valuation. We derive our TP based on a DCF H-model with assumptions for continuous growth motivated by higher penetration rates and incremental contribution by subsidiaries. We believe the stock will continue to outperform on upside to earning estimates.


Source/Extract/Excerpts/来源/转贴/摘录: AmFraser-Research,
Publish date: 02/08/13

No comments:

Post a Comment

Warren E. Buffett(沃伦•巴菲特)
Be fearful when others are greedy, and be greedy when others are fearful
别人贪婪时我恐惧, 别人恐惧时我贪婪
投资只需学好两门课: 一,是如何给企业估值,二,是如何看待股市波动
吉姆·罗杰斯(Jim Rogers)
“错过时机”胜于“搞错对象”:不会全军覆没!”
做自己熟悉的事,等到发现大好机会才投钱下去

乔治·索罗斯(George Soros)

“犯错误并没有什么好羞耻的,只有知错不改才是耻辱。”

如果操作过量,即使对市场判断正确,仍会一败涂地。

李驰(中国巴菲特)
高估期间, 卖对, 不卖也对, 买是错的。
低估期间, 买对, 不买也是对, 卖是错的。

Tan Teng Boo


There’s no such thing as defensive stocks.Every stock can be defensive depending on what price you pay for it and what value you get,
冷眼(冯时能)投资概念
“买股票就是买公司的股份,买股份就是与陌生人合股做生意”。
合股做生意,则公司股份的业绩高于一切,而股票的价值决定于盈利。
价值是本,价格是末,故公司比股市重要百倍。
曹仁超-香港股神/港股明灯
1.有智慧,不如趁势
2.止损不止盈
成功者所以成功,是因为不怕失败!失败者所以失败,是失败后不再尝试!
曾淵滄-散户明灯
每逢灾难就是机会,而是在灾难发生时贱价买股票,然后放在一边,耐性地等灾难结束
  • Selected Indexes 52 week range

  • Margin of Safety

    Investment Clock

    World's First Interactive Investment Clock